The inclusion of digital bismuth germanate (BGO) detector material with the Omni Legend system reportedly more than doubles the sensitivity of older PET/CT devices, improves scan times, and enhances the detection of small lesions.
Emphasizing enhanced diagnostic capabilities, improved efficiency and artificial intelligence (AI)-enabled features, GE Healthcare introduced the Omni Legend positron emission tomography/computed tomography (PET/CT) platform at the 35th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain.
GE Healthcare said a key feature of the Omni Legend system is the enhanced sensitivity with the small crystal size of the digital bismuth germanate (BGO) detector. The PET/CT platform reportedly bolsters image quality with Precision DL, a deep neural network that facilitates improved qualitative accuracy and contrast-to-noise ratio.
“Sensitivity and image quality are everything in PET/CT. Omni Legend delivers on both — meeting all our image quality criteria for oncology and providing impressive sensitivity to image high-count tracers for cardiac and neuroimaging, which helps better inform patient diagnoses and monitoring,” noted John Kennedy, Ph.D., a chief physicist in the Nuclear Medicine Department at the Rambam Health Care Campus in northern Israel.
Dr. Kennedy said the Omni Legend PET/CT system enabled his facility to reduce dosing by 40 percent in comparison to previous PET/CT devices and perform up to 35 patient scans in a 9.5-hour shift.
The Omni Legend system also allows hands-free patient positioning with the AI-powered Auto Positioning feature, according to GE Healthcare.
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.